Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Microbiome
New Research into Newborn Gut Microbiome Identifies Three “Pioneer Bacteria” for Babies’ Microbiota Development
The researchers analysed high-resolution genomic information from over 1,200 babies and identified three pioneer bacteria that drive the development of the gut microbiota.
Drug Discovery & Development
Insilico Medicine and Inimmune Pen Collaboration for AI-Powered Immunotherapy Discovery
The two biotechs are working together to overcome specific hurdles in the immunotherapy drug discovery process.
Regulatory
Regeneron’s Bispecific Gets EU Approval After FDA Rejection
The approval means that the bispecific antibody odronextamab can be used to treat adult patients with relapsed or refractory follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) in the EU.
Antibody-based Therapies
MSD to Acquire Bispecific Antibody From Curon in Bid to Diversify Portfolio
The novel investigational clinical stage bispecific antibody targets CD3xCD19 to engage T cells with malignant B cells.
Immunotherapy (Non-Oncology)
CAR T Beyond Cancer: Applying the Cell Therapy for Lupus and Other Autoimmune Diseases
Can CAR T, which has had successes in immuno-oncology, be applied to reset the immune system of autoimmune disease patients?
Immunotherapy (Non-Oncology)
Scientists Develop First Mouse Model with Complete & Functional Human Immune System
The breakthrough in mouse models will allow researchers to study the human immune system in far greater detail at a far greater pace.
Cancer Vaccines
NHS Cancer Vaccine Launchpad to Give Thousands Access to Personalised Cancer Vaccines
NHS England aims to match up to 10,000 cancer patients to suitable personalised cancer vaccine clinical trials by 2030.
Biomarkers & Precision Medicine
AI-Enabled Predictive Biomarker for Patient Response to Immunotherapy Using Easy-to-Measure Features
The predictive biomarker does not require multi-omic or screening data, but rather routine clinical features.
Vaccines
H5N1 Bird Flu Outbreaks: Effect on Vaccines
H5N1 outbreaks in the US have mobilised pandemic preparedness mechanisms with stockpiling of avian flu vaccines.
